Anthony D. Piscopio
Gründer bei OnKure, Inc.
Profil
Anthony D.
Piscopio was the founder of Array BioPharma, Inc. (founded in 1998) where he held the title of Vice President-Chemistry in 2006.
He is also the founder of OnKure, Inc. (founded in 2011) where he currently holds the title of President & Head-Research & Development.
Additionally, he was the founder of Chemizon, Inc. (founded in 2005) where he held the title of Chairman & Chief Executive Officer.
Dr. Piscopio's current job is as a Director at Core Brewing & Distilling Co. LLC.
His former jobs include working as a Principal at Pfizer Inc. and Amgen BV.
He obtained a doctorate degree from the University of Wisconsin.
Aktive Positionen von Anthony D. Piscopio
| Unternehmen | Position | Beginn |
|---|---|---|
OnKure, Inc.
 OnKure, Inc. BiotechnologyHealth Technology OnKure, Inc. engages in the discovery and development of epigenetic therapies for the treatment of cancer. It develops selective inhibitors of histone deacetylases in preclinical models of both hematological and solid tumor cancers. The company was founded by Xuedong Liu and Anthony D. Piscopio in April 2011 and is headquartered in Longmont, CO. | Gründer | 01.04.2011 |
Core Brewing & Distilling Co. LLC
 Core Brewing & Distilling Co. LLC Beverages: AlcoholicConsumer Non-Durables Core Brewing & Distilling Co. LLC engages in the brewing of beer. It offers year-round, limited-release, and taproom beers. The company was founded by Jesse Core in September 2010 and is headquartered in Springdale, AK. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Anthony D. Piscopio
| Unternehmen | Position | Ende |
|---|---|---|
| ARRAY TECHNOLOGIES, INC. | Gründer | 01.01.2006 |
| PFIZER, INC. | Corporate Officer/Principal | - |
Amgen BV
 Amgen BV Pharmaceuticals: MajorHealth Technology Part of Amgen, Inc., Amgen BV is a Dutch biotech company that specializes in using living cells to create biologic medicines. The company has helped pioneer the biotech industry and are committed to discovering, developing, manufacturing, and delivering innovative human therapeutics to patients suffering from serious illnesses. Amgen's medicines treat serious illnesses and typically address diseases with a limited number of treatment options. The company has a presence in approximately 100 countries and have reached millions of people with their products. Amgen has a robust pipeline focused on the pursuit of transformative medicines with large effects in serious diseases, using human genetic validation whenever possible to strengthen the evidence base for as many of their programs as possible. | Corporate Officer/Principal | - |
Chemizon, Inc.
 Chemizon, Inc. Pharmaceuticals: MajorHealth Technology Chemizon, Inc. engages in the provision of drug discovery services. The company was founded by Anthony D. Piscopio on January 18, 2005 and is headquartered in Seongnam, South Korea. | Vorstandsvorsitzender | - |
Ausbildung von Anthony D. Piscopio
| University of Wisconsin | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PFIZER, INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Array BioPharma, Inc.
 Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Array BioPharma, Inc. is a biopharmaceutical company. Its focus is on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and other high-burden diseases. The company's products are BRAFTOVI and MEKTOVI. Its portfolio includes Binimetinib, Selumetinib, Encorafenib, Filanesib, Ipatasertib, Varltinib, Danoprevir, ARRY-797, Larotrectinib, Tucatinib, ARRY-382, Motolimod, Prexasertib, GDC-0575, LOXO-292, LOXO-195, and AK-1830. The company was founded by Kevin Koch, Anthony D. Piscopio, K. C. Nicolaou, and David L. Snitman in 1998 and is headquartered in Boulder, CO. | Health Technology |
Core Brewing & Distilling Co. LLC
Core Brewing & Distilling Co. LLC Beverages: AlcoholicConsumer Non-Durables Core Brewing & Distilling Co. LLC engages in the brewing of beer. It offers year-round, limited-release, and taproom beers. The company was founded by Jesse Core in September 2010 and is headquartered in Springdale, AK. | Consumer Non-Durables |
OnKure, Inc.
OnKure, Inc. BiotechnologyHealth Technology OnKure, Inc. engages in the discovery and development of epigenetic therapies for the treatment of cancer. It develops selective inhibitors of histone deacetylases in preclinical models of both hematological and solid tumor cancers. The company was founded by Xuedong Liu and Anthony D. Piscopio in April 2011 and is headquartered in Longmont, CO. | Health Technology |
Chemizon, Inc.
Chemizon, Inc. Pharmaceuticals: MajorHealth Technology Chemizon, Inc. engages in the provision of drug discovery services. The company was founded by Anthony D. Piscopio on January 18, 2005 and is headquartered in Seongnam, South Korea. | Health Technology |
Amgen BV
Amgen BV Pharmaceuticals: MajorHealth Technology Part of Amgen, Inc., Amgen BV is a Dutch biotech company that specializes in using living cells to create biologic medicines. The company has helped pioneer the biotech industry and are committed to discovering, developing, manufacturing, and delivering innovative human therapeutics to patients suffering from serious illnesses. Amgen's medicines treat serious illnesses and typically address diseases with a limited number of treatment options. The company has a presence in approximately 100 countries and have reached millions of people with their products. Amgen has a robust pipeline focused on the pursuit of transformative medicines with large effects in serious diseases, using human genetic validation whenever possible to strengthen the evidence base for as many of their programs as possible. | Health Technology |